Lotus Eye Hospital and Institute Limited (LOTUSEYE) — Announcement | 18 April 2026

· NSE Neutral
By StockFin Research Team AI-Assisted Analysis Source: BSE/NSE Filings

Lotus Eye Hospital and Institute Limited confirmed it is not classified as a Large Corporate under SEBI’s 2023 circular, meaning it is exempt from mandatory large-corporate disclosure requirements for debt fundraising. This exemption reduces compliance burdens and signals the company operates below the regulatory threshold for significant capital market activities.

📄 View Original Announcement (PDF)

About Lotus Eye Hospital and Institute Limited (LOTUSEYE)

Healthcare · Healthcare · Listed on NSE

Market Cap: ₹226.68 Cr P/E: 1362.5 ROE: 0.3% ROCE: 2.5%

View full LOTUSEYE stock details →

📡 Get AI alerts when LOTUSEYE files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track LOTUSEYE — Free

📊 More LOTUSEYE filings

See all LOTUSEYE filings →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when LOTUSEYE files new disclosures

Track LOTUSEYE filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track LOTUSEYE — Free

Free account · 2 AI queries/day